Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1380 participants.

Also called NCT06157502

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 1,380 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06157502
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06157502. Randomized; triple masking; primary purpose treatment. Start 2024-01-11 (actual); primary completion 2025-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY)
Condition
Ischemic Stroke, Acute
Intervention (Drug)
Shuxuening Injection
Intervention (Other)
Placebo
Lead sponsor
Beijing Tiantan Hospital (class: other)

Record details

Record id
cardio:ct-nct06157502
Content hash
995c9f73d5f01590bb93a8c581d8f50025ec2c89c57188b6d17eea5e5e155705